Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henogen HBV Vaccine vs Fendrix in Dialysis Patients
NCT00291941Phase 3Completed
- Sponsor
- Henogen
- Start
- Feb 2006
- Primary completion
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of adjuvanted hepatitis B vaccine HB-AS02V in hepatitis B (HBV), sponsored by Henogen. Started Feb 2006; status: completed.
02
Drugs
adjuvanted hepatitis B vaccine HB-AS02V
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00291941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291941.